Summary of Evidence-based Guideline for PATIENTS and their FAMILIES FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

 
Share
 

Manage episode 286060329 series 2390927
By Dr. Frederick B. Covington / The International Institute of Therapeutic Intervention and Learning and Dr. Frederick B. Covington. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

This fact sheet is provided to help you understand the current evidence for diagnosing and managing facioscapulohumeral muscular dystrophy (FSHD). The American Academy of Neurology (AAN) is the world’s largest association of neurologists and neuroscience professionals. Neurologists are doctors who identify and treat diseases of the brain and nervous system, including neuromuscular disorders. The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) is an association of neurologists, doctors of physical medicine and rehabilitation (PMR), and other health care professionals. PMR doctors specialize in rehabilitation. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. The AANEM is dedicated to advancing the care of patients with muscle and nerve disorders. Experts from the AAN and AANEM carefully reviewed the available scientific studies on diagnosing and managing FSHD. The following information is based on evidence from those studies and other key information. The information summarizes the main findings of the 2015 AAN and AANEM guideline on FSHD.

1594 episodes